Last reviewed · How we verify
NCT04710901: uTECH
UTECH: Machine Learning for HIV Prevention Among Substance Using GBMSM
NA trial testing uTECH + YMHP in Sexually Transmitted Diseases in 388 participants. Completed in 31 May 2024.
31 May 2024
Quick facts
| Lead sponsor | University of California, Los Angeles |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 388 |
| Start date | 24 November 2020 |
| Primary completion | 31 May 2024 |
| Estimated completion | 31 May 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- uTECH + YMHP
- YMHP
- uTECH
Conditions studied
- Sexually Transmitted Diseases — all drugs for Sexually Transmitted Diseases →
- HIV Infections — all drugs for HIV Infections →
- Implementation Science — all drugs for Implementation Science →
- Substance Use — all drugs for Substance Use →
Sponsor
University of California, Los Angeles
Who can join
18 and older, male only, with Sexually Transmitted Diseases or HIV Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project seeks to develop and test the acceptability, appropriateness and feasibility of uTECH, a novel social media "big data" machine learning intervention for HIV-negative substance-using sexual and gender minority people who have sex with men that aims to reduce HIV transmission risk by integrating biomedical and behavioral risk reduction strategies, including pre-exposure prophylaxis (PrEP) for HIV prevention and medication assisted treatment (MAT) for substance use harm reduction
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Novel Machine Learning HIV Intervention for Sexual and Gender Minority Young People Who Have Sex With Men (uTECH): Protocol for a Randomized Comparison Trial.
Holloway IW, Wu ESC, Boka C, Young N, et al · · 2024 · cited 2× · PMID 39163591 · DOI 10.2196/58448 -
Utilizing Machine Learning for Predicting PrEP Use Status Among Sexual and Gender Minority Young Adults.
Boka C, Yonko EA, Beikzadeh M, Kärkkäinen K, et al · · 2026 · PMID 41519977 · DOI 10.1007/s11121-025-01872-1 -
Identifying Substance Use and High-Risk Sexual Behavior Among Sexual and Gender Minority Youth by Using Mobile Phone Data: Development and Validation Study.
Beikzadeh M, Holloway IW, Kärkkäinen K, Hong C, et al · · 2025 · PMID 40795338 · DOI 10.2196/68013
Verify or expand the search:
- PubMed search for NCT04710901
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sexually Transmitted Diseases
Currently open trials in the same condition.
- NCT07072481 — Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing · NA · recruiting
- NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting
- NCT06503666 — Zambian Informed Motivated Aware Responsible Adolescent Girls and Adults · NA · recruiting
- NCT06579781 — Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study) · NA · recruiting
- NCT05977491 — Point-of-care Tests for Vaginal Discharge in Nepal · NA · active not recruiting
Other University of California, Los Angeles trials
Trials by the same sponsor.
- NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
- NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
- NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
- NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
- NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04710901 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
- Last refreshed: 25 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04710901.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing